MedTrace Logo

Assessment of Fluctuating Parkinson's Disease With Sensor-based Home Monitoring

NCT05247294 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2022-02-18

No results posted yet for this study

Summary

The aim of this study is to implement home-based monitoring (HBM) using remote-capture wearable devices and patient reported outcomes (PROs) in a rather homogeneous subgroup of advanced Parkinson's Disease (PD) patients, suffering from significant motor fluctuations (MF) and Levodopa-induced dyskinesia (LID), over a two-week period.

The investigators aim to provide a more comprehensive picture of patient symptoms, severity, and fluctuations and compare these data to interview-derived clinical data.

Conditions

  • Parkinson Disease

Sponsors & Collaborators

  • AbbVie

    collaborator INDUSTRY

  • Intel Electronics Ltd.

    collaborator UNKNOWN

  • Sheba Medical Center

    lead OTHER_GOV

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-03
Primary Completion
2021-02-24
Completion
2021-02-24

Countries

  • Israel

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05247294 on ClinicalTrials.gov